tradingkey.logo

GeneDx Holdings Corp

WGS
84.290USD
+0.210+0.25%
終値 02/06, 16:00ET15分遅れの株価
2.44B時価総額
776.72直近12ヶ月PER

GeneDx Holdings Corp

84.290
+0.210+0.25%

詳細情報 GeneDx Holdings Corp 企業名

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corpの企業情報

企業コードWGS
会社名GeneDx Holdings Corp
上場日Sep 04, 2020
最高経営責任者「CEO」Stueland (Katherine A)
従業員数1000
証券種類Ordinary Share
決算期末Sep 04
本社所在地333 Ludlow Street
都市STAMFORD
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号06902
電話番号18887291206
ウェブサイトhttps://sema4.com/
企業コードWGS
上場日Sep 04, 2020
最高経営責任者「CEO」Stueland (Katherine A)

GeneDx Holdings Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+12924.00%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+12924.00%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.43K
+437.00%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-16553.00%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+12924.00%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+12924.00%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.43K
+437.00%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-16553.00%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Patients with third party insurance
95.02M
81.39%
Institutional customers
17.87M
15.31%
Other
3.22M
2.76%
Self pay patients
629.00K
0.54%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
Patients with third party insurance
95.02M
81.39%
Institutional customers
17.87M
15.31%
Other
3.22M
2.76%
Self pay patients
629.00K
0.54%

株主

更新時刻: Sat, Jan 31
更新時刻: Sat, Jan 31
株主統計
種類
株主統計
株主統計
比率
Corvex Management LP
10.58%
Casdin Capital, LLC
10.40%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
他の
64.96%
株主統計
株主統計
比率
Corvex Management LP
10.58%
Casdin Capital, LLC
10.40%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
他の
64.96%
種類
株主統計
比率
Investment Advisor/Hedge Fund
33.56%
Investment Advisor
33.01%
Hedge Fund
30.92%
Corporation
10.65%
Research Firm
6.77%
Individual Investor
1.69%
Pension Fund
0.74%
Venture Capital
0.31%
Sovereign Wealth Fund
0.29%

機関投資家保有株

更新時刻: Wed, Jan 21
更新時刻: Wed, Jan 21
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q4
456
30.28M
113.16%
--
2025Q4
496
30.67M
106.12%
-3.46M
2025Q3
446
32.52M
112.51%
-918.42K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Corvex Management LP
3.06M
10.58%
--
--
Sep 30, 2025
Casdin Capital, LLC
3.01M
10.4%
-38.49K
-1.26%
Sep 30, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.75%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.74%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.32M
4.56%
+37.99K
+2.97%
Sep 30, 2025
William Blair Investment Management, LLC
1.22M
4.22%
-411.26K
-25.21%
Sep 30, 2025
The Vanguard Group, Inc.
1.17M
4.03%
-10.50K
-0.89%
Sep 30, 2025
Goldman Sachs & Company, Inc.
1.00M
3.47%
+28.59K
+2.94%
Sep 30, 2025
Oracle Investment Management, Inc.
889.95K
3.08%
-32.50K
-3.52%
Sep 30, 2025
Summit Partners Public Asset Management, LLC
823.57K
2.85%
+56.30K
+7.34%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Global X Genomics & Biotechnology ETF
3.84%
Franklin Genomic Advancements ETF
3.47%
Clough Hedged Equity ETF
2.89%
Clough Select Equity ETF
2.65%
State Street SPDR S&P Health Care Services ETF
2.27%
Harbor Health Care ETF
1.85%
Innovator IBD Breakout Opportunities ETF
1.52%
ARK Genomic Revolution ETF
1.29%
Main Thematic Innovation ETF
1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
詳細を見る
Global X Genomics & Biotechnology ETF
比率3.84%
Franklin Genomic Advancements ETF
比率3.47%
Clough Hedged Equity ETF
比率2.89%
Clough Select Equity ETF
比率2.65%
State Street SPDR S&P Health Care Services ETF
比率2.27%
Harbor Health Care ETF
比率1.85%
Innovator IBD Breakout Opportunities ETF
比率1.52%
ARK Genomic Revolution ETF
比率1.29%
Main Thematic Innovation ETF
比率1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
比率1.18%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
日付
配当落ち日
種類
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
KeyAI